SMARCB1 and neoplasm: The ATRT subgroups ATRT-TYR, ATRT-SHH, and ATRT-MYC are not only different in regard to their DNA methylation profiles and their transcriptomes, but also harbor different kinds of tumor-driving SMARCB1 alterations [19].